Peru - Spanish - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

laboratorios bago del peru s.a. - diclorhidrato de mitoxantrona; - solucion inyectable - por ampolla ; diclorhidrato de mitoxantrona 23.280000 mg; - mitoxantrona

European Union - Spanish - EMA (European Medicines Agency)

roche registration gmbh  - entrectinib - cancer; carcinoma, non-small-cell lung - agentes antineoplásicos - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.